Drug recall · July 31, 2013
Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For Intravenous Use and recall
Why: Presence of Particulate Matter; particulate found in retain samples
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast Imaging. For Intravenous Use and Reconstitution. a) Five vials kits: NDC# 45567-0555-1, b) Thirty vials kits: NDC# 45567-0555-2, Rx Only, Manufactured by: Pharmalucence, Inc., Billerica, MA 01821
- Lots / codes
Lot 280011, Exp 08/13
- Quantity
- 17,260 vials
- Company
- Pharmalucence, Inc., Billerica, MA
- Distribution
- Nationwide & Bahamas, Barbados, Bermuda, Japan
- Initiated
- May 30, 2013 · Voluntary: Firm initiated
- Classified
- July 19, 2013
- Reported
- July 31, 2013
- Ended
- October 17, 2013
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.